Menu Back toSession-15-Post-Marketing-Safety-Regulations-EU

Drug Safety and Pharmacovigilance Across the Product Lifecycle

Build a solid foundation in the key concepts of drug safety and pharmacovigilance throughout the medical product development lifecycle. Learn how to comply with regulatory requirements.

Session 15: Post-Marketing Safety Regulations – EU

Session Chair(s)

Jill W. Buckley, PharmD

Jill W. Buckley, PharmD

  • Adjunct Assistant Professor
  • Rutgers, the State University of New Jersey, United States
This session will discuss EU Good Pharmacovigilance Practices (GVP) which are a set of measures drawn up to facilitate the performance of the safety monitoring of medicines in the European Union.

Contact us

Registration Questions?

Send Email

Agenda and Event Logistics

Send Email